Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

drugs

A few weeks back, in what has become a seminal Equity.Guru piece about the quickly legalizing safe supply drug space, I tore into PharmaDrug (PHRX.C), which was lurching into…
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release.   Treosulfan will be sold in Canada using the brand name…
In lieu of the American markets not opening today courtesy of the civic holiday, Xphyto Therapeutics (XPHY.C) has elected to provide a glimpse into their business strategy and milestones…
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced…
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with more upside, with less…
Over twenty million people worldwide have contracted COVID-19. Of those 12.4 million have recovered and approximately 738,000 have died at the time of writing, according to Johns Hopkins University…
If you’ve had your eye off the biotech sector recently because it doesn’t directly involve gold or cannabis, you’re missing out on one of the better casinos out there….
CROP Infrastructure (CROP.C) is expanding its hemp CBD production in Italy and attracting the attention of Italian pharmaceutical companies in time for the 2019 growing season. The joint venture…